Identification and Pharmacological Characterization of Prokineticin 2β as a Selective Ligand for Prokineticin Receptor 1

Prokineticins 1 and 2 (PK1 and PK2) have been recently identified from humans and other mammals and play multiple functional roles. PK proteins are ligands for two G protein-coupled receptors, PK receptor 1 (PKR1) and PK receptor 2 (PKR2). Here, we report the molecular cloning and pharmacological ch...

Full description

Saved in:
Bibliographic Details
Published inMolecular pharmacology Vol. 67; no. 6; p. 2070
Main Authors Jingcai Chen, Chester Kuei, Steven Sutton, Sandy Wilson, Jingxue Yu, Fredrik Kamme, Curt Mazur, Timothy Lovenberg, Changlu Liu
Format Journal Article
LanguageEnglish
Published American Society for Pharmacology and Experimental Therapeutics 01.06.2005
Online AccessGet full text

Cover

Loading…
More Information
Summary:Prokineticins 1 and 2 (PK1 and PK2) have been recently identified from humans and other mammals and play multiple functional roles. PK proteins are ligands for two G protein-coupled receptors, PK receptor 1 (PKR1) and PK receptor 2 (PKR2). Here, we report the molecular cloning and pharmacological characterization of an alternatively spliced product of the PK2 gene encoding 21 additional amino acids compared with PK2, designated PK2L (for PK2 long form). PK2L mRNA is broadly expressed, as is PK2. However, PK2L mRNA expression is lower in brain, undetectable in kidney, and much higher in lung and spleen than that of PK2. We expressed PK2L in mammalian cells and characterized the resulting peptide in comparison with PK1 and PK2. Biochemical characterization indicates that secreted PK2L protein is processed into a smaller peptide by proteolytic cleavage. We designate this smaller form of peptide as PK2β. Coexpression of furin with PK2L significantly increased the PK2β processing efficiency. Functional studies showed that PK1, PK2, and PK2β stimulate intracellular Ca 2+ responses in PKR1-expressing cells with similar potencies. However, the PK2β stimulus of Ca 2+ responses in PKR2-expressing cells is at least 10-fold less potent than that of PK1 or PK2. Differences in receptor selectivity combined with differential tissue expression patterns suggest PK2 and PK2β might have different functions in vivo. PKRs have been reported to couple to G q and G i proteins. In this report, we show that PKs not only stimulate Ca 2+ mobilization but also induce cAMP accumulation in PKR-expressing cells.
ISSN:0026-895X
1521-0111
DOI:10.1124/mol.105.011619